UNSPSC 51131909: Albumin human

This classification denotes a peptide fragment derived from human blood plasma, or that residual portion of blood that is left after removal of blood cells by centrifugation without prior blood coagulation, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZIF514RVZR. European Medicines Agency schedules albumin human in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB12026MIG, SUB12761MIG, SUB50207, and SUB62389. As of Q4 2014, ALBUMIN HUMAN remains the US FDA Preferred Term for this commodity.

UNSPSC 51131909 Albumin human is a Commodity code tracking procurement of human albumin, a blood plasma protein used in medical transfusions and clinical treatments at hospitals, emergency departments, and trauma centers. State and local governments purchase albumin through health departments, county hospitals, city medical facilities, and public health systems to maintain emergency blood product inventories and support patient care protocols. The product is sourced from blood banks, plasma collection centers, and pharmaceutical distributors who process and fractionate human plasma into albumin for intravenous administration.

The code shows minimal recent procurement activity in the state and local market. No posted solicitations appear in the available opportunity records for this Commodity code.